Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor

Modern Rheumatology

Volumn 21, Issue 3, 2011, Pages 244-250

  Origuchi, Tomoki ^a   Iwamoto, Naoki ^a   Kawashiri, Shin Ya ^a   Fujikawa, Keita ^a   Aramaki, Toshiyuki ^a   Tamai, Mami ^a   Arima, Kazuhiko ^a   Nakamura, Hideki ^a   Yamasaki, Satoshi ^a   Ida, Hiroaki ^a   Kawakami, Atsushi ^a   Ueki, Yukitaka ^b   Matsuoka, Naoki ^c   Nakashima, Munetoshi ^d   Mizokami, Akinari ^e   Kawabe, Yojiro ^f   Mine, Masanobu ^g   Fukuda, Takaaki ^h   Eguchi, Katsumi ⁱ  

^a NAGASAKI UNIVERSITY   (Japan)

^b Sasebo Central Hospital   (Japan)

^c Nagasaki Medical Hospital of Rheumatology   (Japan)

^d JAPANESE RED CROSS SOCIETY   (Japan)

^e NAGASAKI UNIVERSITY   (Japan)

^f Ureshino Medical Center   (Japan)

^g Suga Orthopedic Hospital   (Japan)

^h KURUME UNIVERSITY MEDICAL CENTER   (Japan)

ⁱ Sasebo Shiritsu Sogo Hospital   (Japan)

Author keywords

Calcitonin gene related peptide (CGRP); Etanercept; Gastrin releasing peptide (GRP); Rheumatoid arthritis; Substance P

Indexed keywords

C REACTIVE PROTEIN; CALCITONIN GENE RELATED PEPTIDE; ETANERCEPT; GASTRIN RELEASING PEPTIDE; SUBSTANCE P;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; GASTRIN-RELEASING PEPTIDE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SUBSTANCE P; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960137307     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0384-5     Document Type: Article

References (38)

1. LJ Roberts 2004 New drugs for rheumatoid arthritis N Engl J Med 351 2659 2661 15602032 10.1056/NEJM200412163512522 1:CAS:528:DC%2BD2cXhtV2qurrF (Pubitemid 39628594)
2. L Klareskog D van der Heijde JP de Jager A Gough J Kalden M Malaise, et al. 2004 Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 363 675 681 15001324 10.1016/S0140-6736(04)15640-7 1:CAS:528:DC%2BD2cXhs12jur4%3D (Pubitemid 38296553)
3. ME Weinblatt JM Kremer AD Bankhurst KJ Bulpitt RM Fleischmann RI Fox, et al. 1999 A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 4 253 259 9920948 10.1056/NEJM199901283400401 1:CAS:528:DyaK1MXht1Wqsbk%3D (Pubitemid 29063266)
4. A Iwasaki K Inoue S Hukuda 1995 Distribution of neuropeptide-containing nerve fibers in the synovium and adjacent bone of the rat knee joint Clin Exp Rheumatol 13 173 178 7544709 1:STN:280:DyaK2MzosFantQ%3D%3D
5. HJ Im X Li P Muddasani GH Kim F Davis J Rangan CB Forsyth, et al. 2008 Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes J Cell Physiol 215 2 452 463 17960584 10.1002/jcp.21317 1:CAS:528:DC%2BD1cXksFWksL0%3D (Pubitemid 351468957)
6. SD Brain TJ Williams JR Tippins HR Morris I MacIntyre 1985 Calcitonin gene-related peptide is a potent vasodilator Nature 313 54 56 3917554 10.1038/313054a0 1:CAS:528:DyaL2MXntlWrtg%3D%3D (Pubitemid 15192304)
7. J McCulloch R Uddman TA Kingman L Edvinsson 1986 Calcitonin gene-related peptide: functional role in cerebrovascular regulation Proc Natl Acad Sci USA 83 5731 5735 3488550 10.1073/pnas.83.15.5731 1:CAS:528:DyaL28XltV2itr4%3D (Pubitemid 16001291)
8. MG Rosenfeld JJ Mermod SG Amara LW Swanson PE Sawchenko J Rivier, et al. 1983 Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing Nature 304 129 135 6346105 10.1038/304129a0 1:CAS:528:DyaL3sXlslSmtrs%3D (Pubitemid 13079138)
9. F Arnalich E de Miguel C Perez-Ayala M Martinez JJ Vazquez J Gijon-Banos, et al. 1994 Neuropeptides and interleukin-6 in human joint inflammation relationship between intraarticular substance P and interleukin-6 concentrations Neurosci Lett 170 251 254 7520139 10.1016/0304-3940(94)90331-X 1:CAS:528:DyaK2cXksFGks74%3D (Pubitemid 24126870)
10. I Lygren M Ostensen PG Burhol G Husby 1986 Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease Ann Rheum Dis 45 637 640 2874778 10.1136/ard.45.8.637 1:STN:280:DyaL283psVOktQ%3D%3D (Pubitemid 16038562)
11. A Pert TW Moody CB Pert LA Dewald J Rivier 1980 Bombesin: receptor distribution in brain and effects on nociception and locomotor activity Brain Res 193 209 220 6247029 10.1016/0006-8993(80)90958-0 1:CAS:528: DyaL3cXks1WqtL0%3D (Pubitemid 10120976)
12. Y Okuma K Yokotani Y Osumi 1995 Centrally applied bombesin increases nerve activity of both sympathetic and adrenal branch of the splanchnic nerves Jpn J Pharmacol 68 227 230 7563982 10.1254/jjp.68.227 1:CAS:528: DyaK2MXmsFCjsr4%3D
13. T Westermark S Rantapaa-Dahlqvist S Wallberg-Jonsson U Kjorell S Forsgren 2001 Increased content of bombesin/GRP in human synovial fluid in early arthritis: different pattern compared with substance P Clin Exp Rheumatol 19 715 720 11791645 1:STN:280:DC%2BD38%2Fmslejtg%3D%3D (Pubitemid 34026837)
14. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
15. M Lotz DA Carson JH Vaughan 1987 Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis Science 235 893 895 2433770 10.1126/science.2433770 1:CAS:528:DyaL2sXhtlKgurc%3D (Pubitemid 17019128)
16. MM Cerinic Y Konttinen S Generini M Cutolo 1998 Neuropeptides and steroid hormones in arthritis Curr Opin Rheumatol 10 220 235 9608325 10.1097/00002281-199805000-00011 1:CAS:528:DyaK1cXjvVCrsLs%3D (Pubitemid 28286812)
17. P Alstergren A Appelgren B Appelgren S Kopp T Lundeberg E Theodorsson 1995 Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis Arch Oral Biol 40 127 135 7540832 10.1016/0003-9969(94)00141-W 1:STN:280:DyaK2MzhsVCktA%3D%3D
18. A Appelgren B Appelgren S Eriksson S Kopp T Lundeberg M Nylander, et al. 1991 Neuropeptides in temporomandibular joints with rheumatoid arthritis: a clinical study Scand J Dent Res 99 519 521 1722347 1:STN:280: DyaK387gvVeksg%3D%3D
19. A Hernanz E De Miguel N Romera C Perez-Ayala J Gijon F Arnalich 1993 Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease Br J Rheumatol 32 31 35 7678534 10.1093/rheumatology/32.1.31 1:STN:280:DyaK3s7js1ynsw%3D%3D (Pubitemid 23053588)
20. O Grimsholm S Rantapaa-Dahlqvist S Forsgren 2005 Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis Arthritis Res Ther 7 R416 R426 15899028 10.1186/ar1503
21. JD Levine R Clark M Devor C Helms MA Moskowitz AI Basbaum 1984 Intraneuronal substance P contributes to the severity of experimental arthritis Science 226 547 549 6208609 10.1126/science.6208609 1:CAS:528:DyaL2MXpslw%3D (Pubitemid 14018526)
22. HC Seegers PS Avery DF McWilliams L Haywood DA Walsh 2004 Combined effect of bradykinin B2 and neurokinin-1 receptor activation on endothelial cell proliferation in acute synovitis FASEB J 18 762 764 14766794 1:CAS:528:DC%2BD2cXjtVyrtr8%3D
23. B Zhang T Muneta K Yagishita I Sekiya 2006 Substance P immunoreactive fibers of synovial tissue in patients with anterior cruciate ligament injury Knee Surg Sports Traumatol Arthrosc 14 404 410 16391948 10.1007/s00167-005-0707- 9 (Pubitemid 44112872)
24. LM Katz CM Marr J Elliott 2003 Characterisation of the response of equine digital arteries and veins to substance P J Vet Pharmacol Ther 26 361 368 14633189 10.1046/j.1365-2885.2003.00491.x 1:CAS:528:DC%2BD3sXps1KgurY%3D (Pubitemid 37378513)
25. DW Pascual KL Bost 1990 Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide Immunology 71 52 56 1698717 1:CAS:528:DyaK3MXpslY%3D (Pubitemid 20296071)
26. J Sato N Segami Y Yoshitake K Kaneyama H Yoshimura K Fujimura, et al. 2007 Specific expression of substance P in synovial tissues of patients with symptomatic, non-reducing internal derangement of the temporomandibular joint: comparison with clinical findings Br J Oral Maxillofac Surg 45 372 377 17098338 10.1016/j.bjoms.2006.09.011 (Pubitemid 46780177)
27. J Larsson A Ekblom K Henriksson T Lundeberg E Theodorsson 1991 Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis Scand J Rheumatol 20 326 335 1947895 10.3109/03009749109096808 1:STN:280:DyaK38%2FlsVeksA%3D%3D
28. H Sakuta K Inaba S Muramatsu 1995 Calcitonin gene-related peptide enhances cytokine-induced IL-6 production by fibroblasts Cell Immunol 165 20 25 7671321 10.1006/cimm.1995.1182 1:CAS:528:DyaK2MXot1Wgsb4%3D
29. F Wang I Millet K Bottomly A Vignery 1992 Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes J Biol Chem 267 21052 21057 1383217 1:CAS:528:DyaK38XlsV2jt78%3D
30. Y Nong R Titus J Ribeiro HG Remold 1989 Peptides encoded by the calcitonin gene inhibit macrophage function J Immunol 143 45 49 2543703 1:CAS:528:DyaL1MXksFSqsro%3D (Pubitemid 19174197)
31. O Grimsholm Y Guo T Ny S Rantapaa-Dahlqvist S Forsgren 2007 Are neuropeptides important in arthritis? Studies on the importance of bombesin/GRP and substance P in a murine arthritis model Ann N Y Acad Sci 1110 525 538 17911468 10.1196/annals.1423.056 1:CAS:528:DC%2BD2sXht1GitL%2FO (Pubitemid 350043042)
32. F Iannone G Lapadula 1998 Neuropeptides and human osteoarthritis J Rheumatol 25 386 388 9489840 1:STN:280:DyaK1c7kvFCrtg%3D%3D
33. M Lotz JH Vaughan DA Carson 1988 Effect of neuropeptides on production of inflammatory cytokines by human monocytes Science 241 1218 1221 2457950 10.1126/science.2457950 1:CAS:528:DyaL1cXlsVeitbY%3D
34. MC Cuesta L Quintero H Pons H Suarez-Roca 2002 Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells Neurochem Int 40 301 306 11792459 10.1016/S0197-0186(01)00094-8 1:CAS:528:DC%2BD38XktVKquw%3D%3D (Pubitemid 34131603)
35. D Kane JC Lockhart PV Balint C Mann WR Ferrell IB McInnes 2005 Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint) Ann Rheum Dis 64 325 327 15155371 10.1136/ard.2004.022277 1:STN:280:DC%2BD2M%2FitVOrsQ%3D%3D (Pubitemid 40193639)
36. PG Green 2005 Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis Arthritis Res Ther 7 111 113 15899059 10.1186/ar1746 1:CAS:528:DC%2BD2MXkt1equrc%3D (Pubitemid 40775171)
37. A Hernanz S Medina E de Miguel E Martin-Mola 2003 Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients Regul Pept 115 19 24 12873794 10.1016/S0167-0115(03) 00127-7 1:CAS:528:DC%2BD3sXlsVajsLw%3D (Pubitemid 36851595)
38. A Hernanz E Tato M De la Fuente E de Miguel F Arnalich 1996 Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects J Neuroimmunol 71 25 30 8982099 10.1016/S0165-5728(96)00118-X 1:CAS:528:DyaK28XmvFemsLY%3D (Pubitemid 26413252)